Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,373 | 1,704 | 2,925 | 2,805 | 2,145 |
| Marketable Securities | 840 | 18 | 39 | 63 | 472 |
| Receivables | 6,523 | 6,044 | 5,347 | 5,150 | 5,152 |
| Inventories | 900 | 851 | 919 | 873 | 928 |
| Other current assets | 421 | 427 | 1,267 | 845 | 484 |
| TOTAL | $10,637 | $9,610 | $11,141 | $10,305 | $9,717 |
| Non-Current Assets | |||||
| PPE Net | 14,427 | 13,603 | 15,179 | 4,028 | 3,805 |
| Investments And Advances | 308 | 308 | 308 | 308 | 308 |
| Intangibles | 16,832 | 17,096 | 17,360 | 17,624 | 17,889 |
| Other Non-Current Assets | 23,931 | 24,271 | 22,778 | 23,129 | 23,090 |
| TOTAL | $55,497 | $55,278 | $55,624 | $45,090 | $45,091 |
| Total Assets | $66,134 | $64,888 | $66,765 | $55,395 | $54,808 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,773 | 2,273 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,364 | 1,605 | 1,793 | 1,723 | 1,848 |
| Accrued Expenses | 3,075 | 3,586 | 2,185 | 2,075 | 2,104 |
| Other current liabilities | 2,000 | 1,983 | 1,966 | 1,950 | 1,933 |
| TOTAL | $18,912 | $19,481 | $23,624 | $15,712 | $16,387 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,548 | 8,580 | 8,609 | N/A | N/A |
| Deferred Revenues | 9,253 | 9,586 | 9,546 | 9,292 | 9,057 |
| Other Non-Current Liabilities | 2,115 | 2,351 | 2,246 | 1,904 | 2,017 |
| TOTAL | $47,910 | $46,931 | $45,527 | $35,277 | $34,170 |
| Total Liabilities | $66,822 | $66,412 | $69,151 | $50,988 | $50,557 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,304 | 8,443 | 8,519 | 8,388 | 8,460 |
| Common Shares | 149 | 149 | 149 | 147 | 147 |
| Retained earnings | -20,871 | -21,638 | -22,475 | -15,269 | -15,904 |
| Other shareholders' equity | 124 | 367 | 495 | -238 | 358 |
| TOTAL | $-688 | $-1,524 | $-2,386 | $4,407 | $4,251 |
| Total Liabilities And Equity | $66,134 | $64,888 | $66,765 | $55,395 | $54,808 |